(Q45008516)

8 December 2017

title

Interpreting results of prostate-specific antigen testing for early detection of prostate cancer (English)

1 reference

8 December 2017

4

1 reference

8 December 2017

3

J E Oesterling

1 reference

8 December 2017

J B Meigs

1

1 reference

8 December 2017

M J Barry

series ordinal

2

1 reference

8 December 2017

publication date

1 September 1996

1 reference

Journal of General Internal Medicine

8 December 2017

published in

1 reference

8 December 2017

volume

11

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

505-512

1 reference

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

8 December 2017

cites work

1 reference

12 December 2020

Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers

1 reference

12 December 2020

The role of increasing detection in the rising incidence of prostate cancer

1 reference

12 December 2020

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

12 December 2020

Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing

1 reference

12 December 2020

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

12 December 2020

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

12 December 2020

What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker

1 reference

12 December 2020

Analysis of variation in prostate-specific antigen values

1 reference

12 December 2020

The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men

1 reference

12 December 2020

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

12 December 2020

Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate

1 reference

12 December 2020

The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia

1 reference

12 December 2020

Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group

1 reference

12 December 2020

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate

1 reference

12 December 2020

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

12 December 2020

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

12 December 2020

Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer

1 reference

12 December 2020

Likelihood ratios for continuous test results--making the clinicians' job easier or harder?

1 reference

12 December 2020

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

12 December 2020

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

12 December 2020

Likelihood ratios with confidence: sample size estimation for diagnostic test studies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02599596

1 reference

Dimensions Publication ID

8 December 2017

1045142193

0 references

1 reference